I do agree that stock is getting a little rich but FDA approval in 4 months, potential CVT approval 8 months. Novo is already working on improved formulation, they are starting lot’s of studies for obesity, kidney and retina problems, etc so Novo really sees this as a potential wonder drug. Also, EMA, Canadian approvals are in pipeline.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.